Cullinan Therapeutics, Inc. Common Stock (NASDAQ: CGEM) last traded at $15.53, up 0.45% on the session. The quote above updates while this page is open; the figures below are drawn from Cullinan Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Cullinan Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker CGEM. Its market capitalisation is $999.43 million.
Valuation measures for Cullinan Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $999.43M |
|---|---|
| Enterprise value | $962.82M |
| Price / book | 2.45 |
| Beta | 1.59 |
Trailing-twelve-month figures tagged in Cullinan Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$204.69M |
| Return on equity | -50.08% |
|---|
| Cash | $78.64M |
|---|
Range and volume for CGEM over the past 52 weeks.
| 52-week high | $23.19 |
|---|---|
| 52-week low | $6.73 |
| Volume | 567.5K |
| Average volume | 877.0K |
| Previous close | $15.46 |
Invest a chosen dollar amount in Cullinan Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CGEM.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.